Skip to main content
OpenTrials
Completed

NCT Number: NCT07078396

Duration and Quality of 1% Ropivacaine Ankle Blocks

The goal of this observational study is to determine the analgesic duration and analgesic quality of a 1% ropivacaine ankle block in forefoot surgery. Bilateral cases of forefoot surgery, preoperative use of steroids, preexisting lower extremity neuropathy, or failed blocks were not included in this quality improvement program.

An ankle block with 1% ropivcaine and patient follow-up is part of the standard practice at Ziekenhuis Oost-Limburg.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

All sexes

Study type

Observational

Primary location

Ziekenhuis Oost-Limburg

Genk, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who underwent unilateral elective forefoot surgery under ankle block with 1% ropivacaine between December 2023 and April 2024 at Ziekenhuis Oost-Limburg, Genk, Belgium.

Exclusion criteria

  • Bilateral cases of forefoot surgery
  • Preoperative use of steroids,
  • Preexisting lower extremity neuropathy
  • Failed blocks

Treatment and study plan

Primary outcomes

  1. Duration sensory block

    Time frame: A maximum of 72 hours until return of sensation is expected.

    Every patient was contacted by phone to assess the duration of analgesia, maximum pain scores within the first 24 hours and patient satisfaction with analgesia on a 10-point visual analog scale (VAS), opioid consumption in the first 24 hours, sleep quality, side effects, and ease of mobilization. If the sensory block had not disappeared at the moment of the survey or if the patient could not be reached, the patient was called again the day after.

Sponsors and collaborators

Lead sponsor

Ziekenhuis Oost-Limburg

Other

Registry information

Official study title

Duration and Analgesic Quality of 1% Ropivacaine Ankle Blocks for Forefoot Surgeries - A Retrospective Analysis

Acronym: AQAB

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jul 22, 2025
Registry last updated
Jul 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.